DistantNews
UK trials bird flu vaccine using mRNA technology
🇬🇧 United Kingdom /Health & Science

UK trials bird flu vaccine using mRNA technology

From BBC News · (1d ago) English

Translated from English, summarized and contextualized by DistantNews.

TLDR

  • UK begins human trials for an mRNA vaccine targeting the H5N1 bird flu strain.
  • The trial aims to recruit 4,000 volunteers, including those in high-risk groups like poultry workers and the elderly.
  • The vaccine's rapid development and potential for large-scale production offer a proactive measure against a possible pandemic.

In a significant step towards bolstering global health security, the United Kingdom has initiated a crucial human trial for an mRNA vaccine designed to combat the H5N1 bird flu strain. This proactive measure, utilizing the same cutting-edge technology behind the COVID-19 vaccines, underscores the UK's commitment to pandemic preparedness.

It was quite easy and it could be something that ultimately proves incredibly important.

— Clare HowardClare Howard, one of the first volunteers to receive the vaccine, shared her experience and optimism about the trial's potential impact.

The trial, which involves 4,000 volunteers across the UK and the United States, focuses on individuals in high-risk professions, such as those working in the poultry industry, and the elderly. This targeted approach ensures that the vaccine's safety and efficacy can be rigorously assessed in populations most vulnerable to the virus.

Although it does not yet move easily between humans, we have to treat human-to-human transmission as a real possibility.

— Dr Rebecca ClarkDr. Rebecca Clark, the trial's national co-ordinating investigator, highlighted the evolving nature of the H5N1 strain and the necessity of preparing for human-to-human transmission.

Scientists emphasize the rapid development capabilities of mRNA technology, which allows for swift adaptation and large-scale production in the event of a pandemic. This contrasts with traditional vaccine development methods, which can be time-consuming and vulnerable to disruptions, particularly with virulent strains like H5N1.

This trial is our proactive attempt to shield against that possibility, and any future pandemic that could emerge from it.

— Dr Rebecca ClarkDr. Clark further elaborated on the trial's objective as a preventative measure against potential future pandemics originating from the H5N1 strain.

The UK's investment in this trial reflects a broader strategy to enhance pandemic resilience. By developing a vaccine against a strain that has caused devastating infections in birds and spread to mammals, the nation is taking a vital step to mitigate the threat of human-to-human transmission and safeguard public health against future outbreaks.

bolstering our pandemic resilience

— Professor Lucy ChappellProfessor Lucy Chappell, chief scientific adviser at the Department of Health and Social Care, described the trial's significance in strengthening the nation's preparedness for health crises.
DistantNews Editorial

Originally published by BBC News in English. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.

More Stories

From Our Blog